Sharechat Logo

Ebos hires Telstra's Shaun Hughes as chief financial officer after promoting Cullity to CEO

Thursday 15th March 2018

Text too small?

Ebos Group has hired Telstra executive Shaun Hughes as chief financial officer after the health-care and pet-care products group promoted John Cullity to chief executive.

Hughes has held executive positions at the Australia telecommunications company since December 2012 and previously worked for Elders and IBM. Cullity becomes CEO on March 31, having been promoted from CFO following the departure of Patrick Davies, which was announced in December. Davies will continue working for Ebos as a contractor.

Davies became CEO in July 2014, having held the top job for six years at Symbion, the pharmaceutical wholesaler and distributor in Australia that Ebos acquired in 2013 for $1.1 billion cash and scrip, a deal which transformed the company and saw profit almost triple in 2014. Symbion’s owner Zuellig Group gained a 40 percent stake in the combined business as a result.

Cullity also joined Ebos in July 2014 after roles at Sigma Pharmaceuticals in Australia and Coca-Cola Co in the US.

Ebos shares dropped 1.8 percent to $18.10 after the market opened this morning, and have slipped 0.6 percent this year.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors